News

DISCLAIMER

“OptiViVax is co-funded from the European Union Horizon Europe programme under grant agreement No. 101080744, UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee (grant No. 10077974) and Swiss Government’s State Secretariat for Education, Research, and Innovation (SERI No. 23.00182).

Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union, UK Research and Innovation or Swiss Government’s State Secretariat for Education, Research, and Innovation. Neither the European Union, UK Research and Innovation or Swiss Government’s State Secretariat for Education, Research, and Innovation nor the granting authority can be held responsible for them.”

News

Contact Us

Mandatory Links